Vassilios Myrianthopoulos

Impact of binding site waters on inhibitor design: contemplating a novel inverse binding mode of indirubin derivatives in DYRK kinases

Daniel Cappel, Vassilios Myrianthopoulos, Emmanuel Mikros, 2014, Journal of Cheminformatics.

A facile consensus ranking approach enhances virtual screening robustness and identifies a cell-active DYRK1α inhibitor.

Vassilios Myrianthopoulos, Emmanuel Mikros, Sofia Vasilakaki, 2018, Future medicinal chemistry.

In Silico Screening of Compound Libraries Using a Consensus of Orthogonal Methodologies.

Vassilios Myrianthopoulos, Emmanuel Mikros, George Lambrinidis, 2018, Methods in molecular biology.

Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis

Vassilios Myrianthopoulos, Emmanuel Mikros, Stefan Knapp, 2016, Journal of medicinal chemistry.

Exploring and exploiting the systemic effects of deregulated replication licensing.

Vassilios Myrianthopoulos, Emmanuel Mikros, Dimitris Thanos, 2016, Seminars in cancer biology.

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases

Daniel Cappel, Vassilios Myrianthopoulos, Emmanuel Mikros, 2012, ACS medicinal chemistry letters.

An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3

Vassilios Myrianthopoulos, Emmanuel Mikros, Konstantina Vougogiannopoulou, 2013, Parasites & Vectors.